Summary
Lam Research Corporation (LRCX) has filed an 8-K report detailing a significant debt financing transaction. The company successfully completed a private offering of $900 million in aggregate principal amount of convertible notes, split between $450 million of 0.50% convertible notes due 2016 and $450 million of 1.25% convertible notes due 2018. The net proceeds from this offering, after accounting for discounts, expenses, and hedging transactions, amounted to approximately $835.6 million. These notes are senior unsecured obligations and are convertible into Lam Research's common stock under specific conditions, with a conversion price of approximately $63.02 per share. The company also engaged in convertible note hedge transactions and sold warrants, which could have a dilutive effect under certain market conditions. Furthermore, the company utilized a portion of the proceeds to repurchase 1 million shares of its common stock at $47.56 per share. This buyback, along with potential future repurchases under its existing program, could influence the market price of its stock and the convertible notes. The notes and underlying shares have not been registered under the Securities Act and were offered to qualified institutional buyers.
Key Highlights
- 1Completion of a $900 million private offering of convertible notes, consisting of $450 million due 2016 and $450 million due 2018.
- 2Net proceeds from the offering totaled approximately $835.6 million after expenses and hedging costs.
- 3The notes are convertible into Lam Research common stock at an initial conversion price of approximately $63.02 per share.
- 4Convertible note hedge and warrant transactions were entered into to manage potential dilution, though warrants could still be dilutive.
- 5Company repurchased 1 million shares of its common stock for $47.56 per share using a portion of the offering proceeds.
- 6Notes are senior unsecured obligations, ranking equally with existing and future unsecured senior indebtedness.
- 7The offering was made to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933.